Compounds and peptides that bind to the erythropoietin receptor
June 30, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod for the purification of erythropoietin and erythropoietin compositions DNA sequences encoding erythropoietin Erythropoietin (EPO) peptides Recombinant DNA endoding an erythropoietin receptor Homogeneous erythropoietin compositions and methods of using same In-vitro method for determining a surreptitious use of exogenous erythropoiesis stimulating agents by a normal living subject Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin Proteinaceous compositions having an activity on erythropoiesis Patent #: 5482924 Inventors
AssigneeApplicationNo. 484635 filed on 06/07/1995US Classes:530/300, PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES435/69.1, Recombinant DNA technique included in method of making a protein or polypeptide530/324, 25 or more amino acid residues in defined sequence530/325, 24 amino acid residues in defined sequence530/326, 15 to 23 amino acid residues in defined sequence530/327, 11 to 14 amino acid residues in defined sequence530/3288 to 10 amino acid residues in defined sequenceExaminersPrimary: Jagannathan, Vasu S.Assistant: Kemmerer, Elizabeth Attorney, Agent or FirmForeign Patent References
International ClassesC07K 007/00C12N 015/09 AbstractPeptides of 10 to 40 or more amino acid residues in length and having the sequence X3 X4 X5 GPX6 TWX7 X8 (SEQ ID NO:252) where each amino acid is indicated by standard one letter abbreviation; X3 is C; X4 is R, H, L, or W; X5 is M, F, or I; X6 is independently selected from any one of the 20 genetically coded L-amino acids; X7 is D, E, I, L, or V; and X8 is C, which bind and activate the erythropoietin receptor (EPO-R) or otherwise act as an EPO agonist, and methods for their use.Other References
Field of SearchPEPTIDES OF 3 TO 100 AMINO ACID RESIDUES25 or more amino acid residues in defined sequence 24 amino acid residues in defined sequence 15 to 23 amino acid residues in defined sequence 11 to 14 amino acid residues in defined sequence 8 to 10 amino acid residues in defined sequence Recombinant DNA technique included in method of making a protein or polypeptide |
| ||||||||||||||
